Q10 and International normalised ratio abnormal - a phase IV clinical study of FDA data

Summary:

International normalised ratio abnormal is reported as a side effect among people who take Q10 (coenzyme q - 10), especially for people who are male, 60+ old, also take Vitamin B12, and have Angiomyolipoma.

The phase IV clinical study analyzes which people have International normalised ratio abnormal when taking Q10. It is created by eHealthMe based on reports of 32,909 people who have side effects when taking Q10 from the FDA, and is updated regularly.

What is Q10?

Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,261 Q10 users. Check the latest studies of Q10.

What is International normalised ratio abnormal?

International normalised ratio abnormal is found to be associated with 324 drugs and 472 conditions by eHealthMe. Check the latest studies of International normalised ratio abnormal.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

32,909 people reported to have side effects when taking Q10.
Among them, 18 people (0.05%) have International normalised ratio abnormal.

Could Q10 cause International normalised ratio abnormal?

Among these 18 people:

What is the gender of people who have International normalised ratio abnormal when taking Q10? *

female: 50 %
male: 50 %

What is the age of people who have International normalised ratio abnormal when taking Q10? *

What are other drugs people take besides Q10? *

What are other side effects people have besides International normalised ratio abnormal? *

Nausea (feeling of having an urge to vomit): 4 people, 22.22%
Nasopharyngitis (inflammation of the nasopharynx): 4 people, 22.22%
Constipation: 4 people, 22.22%
Dyspnea (difficult or laboured breathing): 4 people, 22.22%
Head Injury: 4 people, 22.22%
Gout (uric acid crystals building up in the body): 3 people, 16.67%
Loss Of Consciousness: 3 people, 16.67%
International Normalised Ratio Decreased: 3 people, 16.67%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 3 people, 16.67%
Haematochezia (passage of stools containing blood): 3 people, 16.67%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 16.67%
Cardiac Disorder: 3 people, 16.67%
Angiomyolipoma (most common benign tumour of the kidney): 3 people, 16.67%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 1 person, 5.56%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.56%
Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 1 person, 5.56%
Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 5.56%
Fungal Infection: 1 person, 5.56%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 5.56%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Q10 and have International normalised ratio abnormal?

- Check whether International normalised ratio abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Q10:

Q10 (34,261 reports)

International normalised ratio abnormal treatments and more:

International normalised ratio abnormal (4,071 reports)

How severe was International normalised ratio abnormal and when was it recovered:

International normalised ratio abnormal in Q10

Expand to all the drugs that have ingredients of coenzyme q - 10:

International normalised ratio abnormal and drugs with ingredients of coenzyme q - 10

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Q10:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with International normalised ratio abnormal:

International normalised ratio abnormal (324 drugs)

Browse all the conditions that are associated with International normalised ratio abnormal:

International normalised ratio abnormal (472 conditions)

Related publications that referenced our studies

Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Q10) and Q10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.